FBIO RSI Chart
Last 7 days
15.0%
Last 30 days
8.5%
Last 90 days
3.2%
Trailing 12 Months
276.5%
Historical Charts for Stock Metrics
Year | Q1 | Q2 | Q3 | Q4 |
---|---|---|---|---|
2024 | 85.1M | 0 | 0 | 0 |
2023 | 64.2M | 62.7M | 81.0M | 84.5M |
2022 | 70.2M | 73.0M | 74.4M | 75.7M |
2021 | 44.3M | 52.7M | 64.3M | 68.8M |
2020 | 43.1M | 43.3M | 43.0M | 45.6M |
2019 | 27.5M | 29.9M | 34.5M | 36.6M |
2018 | 152.9M | 67.1M | 25.4M | 26.9M |
2017 | 20.4M | 110.8M | 156.7M | 149.8M |
2016 | 1.0M | 3.3M | 4.2M | 18.3M |
2015 | 0 | 0 | 0 | 863.0K |
2014 | 0 | 0 | 0 | 0 |
2013 | 0 | 0 | 0 | 0 |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
Apr 01, 2024 | jin david | acquired | 3,998 | 1.7 | 2,352 | chief financial officer |
Jan 05, 2024 | rosenwald lindsay a md | bought | 118,770 | 2.3754 | 50,000 | president, ceo & chairman |
Jan 01, 2024 | harvey jimmie | acquired | - | - | 6,666 | - |
Jan 01, 2024 | klein dov | acquired | - | - | 6,666 | - |
Jan 01, 2024 | lorenz kevin | acquired | - | - | 3,333 | - |
Jan 01, 2024 | rowinsky eric k | acquired | - | - | 6,666 | - |
Jan 01, 2024 | rosenwald lindsay a md | acquired | - | - | 216,465 | president, ceo & chairman |
Jan 01, 2024 | weiss michael s | acquired | - | - | 216,465 | see remarks |
Jan 01, 2024 | hoenlein malcolm | acquired | - | - | 3,333 | - |
Jan 01, 2024 | lu lucy | acquired | - | - | 3,333 | - |
Which funds bought or sold FBIO recently?
View All DetailsDatesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
May 16, 2024 | JANE STREET GROUP, LLC | sold off | -100 | -84,759 | - | -% |
May 16, 2024 | B. Riley Wealth Advisors, Inc. | sold off | -100 | -258,785 | - | -% |
May 16, 2024 | B. Riley Wealth Advisors, Inc. | new | - | 42,006 | 42,006 | -% |
May 15, 2024 | ARMISTICE CAPITAL, LLC | sold off | -100 | -1,793,960 | - | -% |
May 15, 2024 | STATE STREET CORP | unchanged | - | -18,651 | 36,932 | -% |
May 15, 2024 | MORGAN STANLEY | reduced | -45.05 | -7,084 | 4,074 | -% |
May 15, 2024 | BANK OF AMERICA CORP /DE/ | reduced | -1.78 | -821 | 1,542 | -% |
May 15, 2024 | Altium Capital Management LP | sold off | -100 | -1,219,420 | - | -% |
May 15, 2024 | Integrated Wealth Concepts LLC | added | 99.34 | 9,833 | 40,132 | -% |
May 15, 2024 | Cetera Investment Advisers | sold off | -100 | -40,451 | - | -% |
Unveiling Fortress Biotech Inc's Major ShareHolders
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Peers (Alternatives to Fortress Biotech Inc)
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
MRNA | 50.9B | 6.8B | -8.53 | 7.44 | ||||
HILS | 22.5B | 216.3K | -2.5K | 104.0K | ||||
ALNY | 18.9B | 2.0B | -56.9 | 9.43 | ||||
BMRN | 14.7B | 2.5B | 71.65 | 5.96 | ||||
INCY | 12.8B | 3.8B | 17.2 | 3.4 | ||||
MID-CAP | ||||||||
BBIO | 5.6B | 107.9M | -10.31 | 48.09 | ||||
APLS | 5.0B | 524.1M | -12.02 | 9.57 | ||||
AXSM | 3.6B | 251.0M | -12.28 | 14.5 | ||||
ARWR | 3.1B | 240.7M | -6.53 | 12.77 | ||||
ACAD | 2.4B | 813.8M | -1.4K | 3 | ||||
SMALL-CAP | ||||||||
CPRX | 1.9B | 411.3M | 29.91 | 4.73 | ||||
NVAX | 1.8B | 996.6M | -4.58 | 1.83 | ||||
CRBP | 480.9M | 881.7K | -14.25 | 481.06 | ||||
INO | 310.9M | 4.9M | -2.49 | 63.89 | ||||
IBIO | 17.1M | 2.1M | -0.74 | 7.61 |
Fortress Biotech Inc News
Income Statement (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 |
Revenue | -34.7% | 13,030,000 | 19,946,000 | 34,752,000 | 17,386,000 | 12,429,000 | 16,404,000 | 16,528,000 | 18,886,000 | 23,925,000 | 21,100,500 | 18,276,000 | 21,085,000 | 17,843,000 | 11,587,000 | 13,749,000 | 9,475,000 | 9,457,000 | 12,918,000 | 11,130,000 | 9,772,000 | 9,250,000 |
Costs and Expenses | 25.4% | 49,596,000 | 39,559,000 | 48,510,000 | 67,491,000 | 71,296,000 | 71,038,000 | 67,262,000 | 69,812,000 | 71,195,000 | - | 82,148,500 | 71,008,000 | 60,700,000 | 41,604,000 | 38,052,000 | 32,518,000 | 34,853,000 | 34,446,000 | 41,511,000 | 32,312,000 | 34,540,000 |
Operating Expenses | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 34,540,000 |
S&GA Expenses | -20.7% | 17,941,000 | 22,611,500 | 21,733,000 | 24,439,000 | 25,341,000 | 28,199,000 | 30,139,000 | 29,048,000 | 26,270,000 | - | 27,698,000 | 22,221,000 | 19,382,000 | 17,542,000 | 15,808,000 | 15,383,000 | 14,456,000 | 15,519,000 | 14,330,000 | 14,339,000 | 13,443,000 |
R&D Expenses | - | 24,839,000 | - | - | - | 39,506,000 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA Margin | -0.2% | -1.65 | -1.65 | -2.49 | -3.18 | -3.11 | -2.65 | -2.05 | -2.11 | -2.16 | -2.21 | -2.25 | -1.46 | -1.75 | -2.08 | -2.03 | -2.12 | -2.16 | -2.18 | -2.57 | -2.80 | - |
Interest Expenses | 22.4% | 1,658,000 | 1,355,000 | 1,459,000 | 2,246,000 | 2,885,000 | 2,824,000 | 2,608,000 | 2,431,000 | 1,556,000 | - | 1,893,000 | 1,686,000 | 1,669,000 | 1,670,000 | 1,535,000 | 3,504,000 | 1,556,000 | 1,609,000 | 1,468,000 | 1,438,000 | 1,438,000 |
Income Taxes | -100.0% | - | 379,000 | 141,000 | 52,000 | -104,000 | 449,000 | - | 59,000 | 107,000 | - | -188,000 | 157,000 | 504,000 | - | 500,000 | - | - | - | -2,388,500 | - | - |
Earnings Before Taxes | 100.0% | - | -28,605,000 | -10,583,000 | - | - | -56,996,000 | -53,060,000 | - | - | - | - | - | - | - | - | - | - | - | -32,955,000 | -24,970,000 | -27,480,000 |
EBT Margin | 0.7% | -1.75 | -1.77 | -2.64 | -3.40 | -3.32 | -2.82 | -2.21 | -2.25 | -2.30 | -2.34 | -2.39 | -1.60 | -1.95 | -2.32 | -2.26 | -2.37 | -2.35 | -2.36 | -2.78 | -3.00 | - |
Net Income | -66.1% | -15,417,000 | -9,279,000 | -5,045,000 | -24,776,000 | -21,537,000 | -26,948,000 | -22,511,000 | -21,356,000 | -15,760,000 | - | -31,565,000 | -20,781,000 | -3,535,000 | -8,822,000 | -5,295,000 | -15,547,000 | -13,314,000 | -12,370,000 | -15,492,000 | -12,762,000 | -13,098,000 |
Net Income Margin | 10.7% | -0.64 | -0.72 | -0.97 | -1.53 | -1.44 | -1.14 | -1.23 | -1.23 | -1.00 | -0.92 | -0.94 | -0.60 | -0.63 | -0.97 | -1.02 | -1.32 | -1.25 | -1.25 | -1.09 | -1.43 | - |
Free Cashflow | 27.3% | -25,415,000 | -34,963,000 | -16,780,000 | -33,325,000 | -43,220,000 | -47,935,000 | -44,253,000 | -41,731,000 | -48,197,000 | -40,653,000 | -40,653,000 | -22,157,000 | -36,150,000 | -22,146,000 | -21,184,000 | -23,371,000 | -18,635,000 | -22,418,000 | -25,942,000 | -16,764,000 | - |
Balance Sheet | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Assets | -1.7% | 165 | 168 | 151 | 181 | 264 | 294 | 324 | 364 | 408 | 397 | 408 | 418 | 391 | 333 | 296 | 269 | 229 | 226 | 222 | 227 | 201 |
Current Assets | -0.4% | 117 | 117 | 98.00 | 128 | 202 | 230 | 258 | 299 | 341 | 346 | 301 | 320 | 318 | 266 | 238 | 200 | 159 | 156 | 166 | 164 | 137 |
Cash Equivalents | 6.1% | 86.00 | 81.00 | 72.00 | 78.00 | 152 | 178 | 208 | 249 | 288 | 308 | 253 | 275 | 290 | 235 | 218 | 183 | 153 | 153 | 151 | 165 | 133 |
Inventory | 3.7% | 11.00 | 10.00 | 11.00 | 12.00 | 13.00 | 14.00 | 15.00 | 16.00 | 16.00 | 10.00 | 12.00 | 14.00 | 2.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
Net PPE | -5.8% | 6.00 | 7.00 | 7.00 | 7.00 | 12.00 | 13.00 | 14.00 | 14.00 | 14.00 | 15.00 | 14.00 | 13.00 | 12.00 | 12.00 | 12.00 | 12.00 | 13.00 | 12.00 | 12.00 | 12.00 | 12.00 |
Liabilities | 1.6% | 169 | 166 | 164 | 197 | 244 | 244 | 222 | 216 | 214 | 171 | 195 | 170 | 147 | 136 | 120 | 152 | 153 | 154 | 147 | 137 | 150 |
Current Liabilities | 3.3% | 88.00 | 85.00 | 97.00 | 129 | 129 | 128 | 106 | 105 | 103 | 101 | 103 | 71.00 | 54.00 | 52.00 | 37.00 | 57.00 | 52.00 | 46.00 | 47.00 | 36.00 | 49.00 |
Long Term Debt | - | - | - | - | - | - | - | - | - | - | - | 18.00 | 13.00 | 11.00 | - | - | - | - | - | - | - | - |
LT Debt, Non Current | - | - | - | - | - | - | - | - | - | - | - | 18.00 | 13.00 | 11.00 | - | - | - | - | - | - | - | - |
Shareholder's Equity | -117.5% | -3.94 | 23.00 | 17.00 | 19.00 | 20.00 | 42.00 | 101 | 148 | 194 | 226 | 212 | 248 | 244 | 197 | 176 | 117 | 75.00 | 73.00 | 75.00 | 90.00 | 51.00 |
Retained Earnings | -2.2% | -710 | -694 | -685 | -680 | -655 | -634 | -607 | -584 | -563 | -547 | -515 | -495 | -491 | -482 | -477 | -461 | -448 | -436 | -420 | -407 | -394 |
Additional Paid-In Capital | 2.2% | 733 | 717 | 702 | 699 | 693 | 676 | 669 | 662 | 661 | 656 | 608 | 603 | 597 | 583 | 574 | 521 | 485 | 462 | 446 | 439 | 415 |
Shares Outstanding | 28.4% | 19.00 | 15.00 | 9.00 | 9.00 | 9.00 | 7.00 | 6.00 | 6.00 | 6.00 | 7.00 | 5.00 | 5.00 | 5.00 | 6.00 | 5.00 | 5.00 | 4.00 | 5.00 | 4.00 | 3.00 | - |
Minority Interest | -28.7% | -26.96 | -20.96 | -29.92 | -34.45 | -17.99 | 8.00 | 40.00 | 70.00 | 96.00 | 117 | 120 | 140 | 138 | 97.00 | 79.00 | 56.00 | 38.00 | 46.00 | 49.00 | 58.00 | 30.00 |
Float | - | - | - | - | 53.00 | - | - | - | 66.00 | - | - | - | 254 | - | - | - | 174 | - | - | - | 71.00 | - |
Cashflow (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Cashflow From Operations | 27.3% | -25,387 | -34,935 | -16,779 | -33,291 | -43,220 | -47,844 | -43,273 | -41,424 | -46,860 | -38,696 | -21,696 | -34,460 | -21,688 | -20,486 | -23,892 | -17,412 | -21,892 | -25,052 | -16,264 | -28,320 | -25,325 |
Share Based Compensation | 31.1% | 4,857 | 3,704 | 4,377 | 4,217 | 4,731 | 5,506 | 6,837 | 5,081 | 5,563 | 7,037 | 4,326 | 4,350 | 3,773 | 3,132 | 3,171 | 3,748 | 3,400 | 2,765 | 3,741 | 3,373 | 3,309 |
Cashflow From Investing | 100.0% | - | -63.00 | 4,999 | -2,039 | -5,000 | -391 | -893 | -307 | -21,337 | 53,353 | -7,541 | -4,840 | -458 | -1,567 | -2,758 | -1,063 | -1,776 | 310 | -3,750 | -611 | 24,148 |
Cashflow From Financing | -36.1% | 27,859 | 43,618 | -2,685 | -30,381 | 22,187 | 18,618 | 3,746 | 2,991 | 49,964 | 38,941 | 6,966 | 24,395 | 78,692 | 37,015 | 46,832 | 65,810 | 22,753 | 27,155 | 5,552 | 61,894 | 52,113 |
Dividend Payments | -100.0% | - | 180 | 185 | 185 | 186 | 186 | 188 | 188 | 187 | 187 | 187 | 188 | 187 | 187 | 50.00 | - | - | - | - | - | - |
Buy Backs | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 70.00 | -82.00 | - | - | - |
Unaudited Condensed Consolidated Statements of Operations - USD ($) $ in Thousands | 3 Months Ended | |
---|---|---|
Mar. 31, 2024 | Mar. 31, 2023 | |
Revenue | ||
Product revenue, net | $ 13,030 | $ 12,165 |
Collaboration revenue | 181 | |
Other revenue | 48 | |
Net revenue | 13,030 | 12,429 |
Operating expenses | ||
Cost of goods sold - product revenue | 6,816 | 6,449 |
Research and development | 24,839 | 35,276 |
Research and development - licenses acquired | 4,230 | |
Selling, general and administrative | 17,941 | 25,341 |
Total operating expenses | 49,596 | 71,296 |
Loss from operations | (36,566) | (58,867) |
Other income (expense) | ||
Interest income | 833 | 1,036 |
Interest expense and financing fee | (2,602) | (4,296) |
Gain (loss) on common stock warrant liabilities | (667) | 6,678 |
Other income (expense) | (21) | 304 |
Total other income (expense) | (2,457) | 3,722 |
Net loss | (39,023) | (55,145) |
Net loss attributable to non-controlling interests | 23,606 | 33,608 |
Net loss attributable to Fortress | (15,417) | (21,537) |
Net loss attributable to common stockholders | $ (17,731) | $ (23,545) |
Net loss per common share attributable to common stockholders - basic | $ (1.03) | $ (3.47) |
Weighted average common shares outstanding - basic | 17,151,945 | 6,792,376 |
Related Party | ||
Revenue | ||
Revenue - related party | $ 35 |
Unaudited Condensed Consolidated Balance Sheets - USD ($) $ in Thousands | Mar. 31, 2024 | Dec. 31, 2023 |
---|---|---|
Current assets | ||
Cash and cash equivalents | $ 83,774 | $ 80,927 |
Accounts receivable, net | 9,799 | 15,222 |
Inventory | 10,580 | 10,206 |
Prepaid expenses and other current assets | 12,071 | 10,500 |
Total current assets | 116,548 | 117,022 |
Property, plant and equipment, net | 6,128 | 6,505 |
Operating lease right-of-use asset, net | 16,462 | 16,990 |
Restricted cash | 2,063 | 2,438 |
Intangible asset, net | 19,473 | 20,287 |
Other assets | 3,971 | 4,284 |
Total assets | 164,645 | 167,526 |
Current liabilities | ||
Accounts payable and accrued expenses | 76,379 | 73,562 |
Income taxes payable | 843 | 843 |
Common stock warrant liabilities | 689 | 886 |
Operating lease liabilities, short-term | 2,601 | 2,523 |
Partner company convertible preferred shares, short-term, net | 4,021 | 3,931 |
Partner company installment payments - licenses, short-term, net | 3,000 | 3,000 |
Other short-term liabilities | 163 | 163 |
Total current liabilities | 87,696 | 84,908 |
Notes payable, long-term, net | 61,420 | 60,856 |
Operating lease liabilities, long-term | 17,619 | 18,282 |
Other long-term liabilities | 1,847 | 1,893 |
Total liabilities | 168,582 | 165,939 |
Commitments and contingencies (Note 14) | ||
Stockholders' equity (deficit) | ||
Cumulative redeemable perpetual preferred stock, $0.001 par value, 15,000,000 authorized, 5,000,000 designated Series A shares, 3,427,138 shares issued and outstanding as of March 31, 2024 and December 31, 2023, respectively, liquidation value of $25.00 per share | 3 | 3 |
Common stock, $0.001 par value, 200,000,000 shares authorized, 19,375,343 and 15,093,053 shares issued and outstanding as of March 31, 2024 and December 31, 2023, respectively | 19 | 15 |
Additional paid-in-capital | 733,290 | 717,396 |
Accumulated deficit | (710,287) | (694,870) |
Total stockholders' equity attributed to the Company | 23,025 | 22,544 |
Non-controlling interests | (26,962) | (20,957) |
Total stockholders' equity (deficit) | (3,937) | 1,587 |
Total liabilities and stockholders' equity (deficit) | 164,645 | 167,526 |
Related Party | ||
Current assets | ||
Other receivables - related party | $ 324 | $ 167 |